CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
16-30 of 1019
Treating the Complex Patient: TD Management in Older Adults and Medically Fragile Populations
MinuteCE®Treating the Complex Patient: TD Management in Older Adults and Medically Fragile Populations
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
MinuteCE®Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
Tracy Hicks, DNP, MBA
Melissa Moody, MD
The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
MinuteCE®The 15-Minute Med Check: Making AIMS and TD Screening Routine in Psychiatry
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Closing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
MinuteCE®Closing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
MinuteCE®Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Tracy Hicks, DNP, MBA
Melissa Moody, MD
- advertisement
Not All VMAT2s Are the Same: Understanding the PK/PD Differences
MinuteCE®Not All VMAT2s Are the Same: Understanding the PK/PD Differences
Tracy Hicks, DNP, MBA
Melissa Moody, MD
When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
MinuteCE®When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
Tracy Hicks, DNP, MBA
From “EPS” to Personalized TD Treatment: Matching VMAT2 MOA to the Patient
MinuteCE®From “EPS” to Personalized TD Treatment: Matching VMAT2 MOA to the Patient
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Francisco Javier Ampudia-Blasco, MD, PhD
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CEImproving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
Continuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
CME/CEContinuing the Search: New Data on Hypercortisolism Prevalence in Difficult-to-Control Metabolic Conditions
Christian Mende, MD, FACP, FACN, FASN, FASH, FAHA
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
- advertisement
Chairperson’s Perspective: TROP2-Targeted ADCs in TNBC and HR+ mBC
CME/CEChairperson’s Perspective: TROP2-Targeted ADCs in TNBC and HR+ mBC
Adam Brufsky, MD, PhD
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CERedefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
